This site is intended for Healthcare Professionals only.

Scotland’s CPO Rose Marie Parr to retire in July

Date:

Share post:

Chief Pharmaceutical Officer for Scotland Rose Marie Parr is retiring from her role in July 2020, Scotland’s Health Secretary Jeane Freeman announced on Friday.

Parr, who has been in the pharmacy profession since 1982, was appointed to the role following the retirement of Professor Bill Scott in 2015.

In a tweet, Freeman said: “Rose Marie Parr has made a significant and valuable contribution as Chief Pharmaceutical Officer over the past 5 years. In her time she has provided consistent leadership and has been an exemplary CPO. I wish her the very best for her retirement when it comes at the end of July.”

https://twitter.com/JeaneF1MSP/status/1235961632079130624

She was the first Chair of the Scottish Pharmacy Board of the Royal Pharmaceutical Society of Great Britain  and was the chair of the GPhC’s Board of Assessors, which oversees the registration assessment.

She also held posts in hospital pharmacy and roles at NHS Education for Scotland.

Parr also holds honorary professorships at both Scottish schools of pharmacy – Strathclyde University and Robert Gordon University.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...